Former coal miners file suit over lung disease

Former coal miners file suit over lung disease

NAGASAKI, Japan - Former coal miners enter the Nagasaki District Court on March 4 to file a lawsuit against Matsushima Coal Mining Co. and its parent firm Mitsui Matsushima Co., both based in Fukuoka. They are seeking compensation for a lung disease.

  • Product Code
  • ILEA000011988
  • Registered date
  • 2002/3/04 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 1224 × 1363 pixel
  • Resolution
  • 72 dpi
  • Deployment size
  • 153.60(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Poland Coal

    Poland Coal

    A view of the coal mine in Brzeszcze, Poland on April 1, 2024. (Photo by Jakub Porzycki/NurPhoto)
      Poland Coal

      Poland Coal

      A view of the coal shaft at the mine in Brzeszcze, Poland on April 1, 2024. (Photo by Jakub Porzycki/NurPhoto)
        U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

        U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

        Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
          U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

          U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

          Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
            U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

            U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

            Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
              Ono Pharmaceutical to dispute suit filed by Nobel laureate

              Ono Pharmaceutical to dispute suit filed by Nobel laureate

              File photo taken June 5, 2020, shows the headquarters of Ono Pharmaceutical Co. in Osaka. The company said in a press release issued July 6 that it will "dispute and cope" with a lawsuit filed by Japanese Nobel laureate in medicine Tasuku Honjo the previous month over patent royalties for the cancer treatment drug Opdivo developed based on the discovery of his research team.
                Coal mine Darkov OKD, test, testing, epidemic coronavirus, employe, infection, protection, miner, army, soldier

                Coal mine Darkov OKD, test, testing, epidemic coronavirus, employe, infection, protection, miner, army, soldier

                The testing in the Darkov black-coal mine in Karvina (pictured May 23, 2020), north Moravia, has revealed 212 COVID cases, 154 of whom are miners or other employees of the mine, 54 are their family members and four work in other mines, Health Minister Adam Vojtech told journalists in Prague, Czech Republic, May 24, 2020. Six of the infected employees are commuters from Poland. The testing related to the Darkov mine will continue until Monday.
                  Coal mine Darkov OKD, test, testing, epidemic coronavirus, employe, infection, protection, miner

                  Coal mine Darkov OKD, test, testing, epidemic coronavirus, employe, infection, protection, miner

                  The testing in the Darkov black-coal mine in Karvina (pictured May 23, 2020), north Moravia, has revealed 212 COVID cases, 154 of whom are miners or other employees of the mine, 54 are their family members and four work in other mines, Health Minister Adam Vojtech told journalists in Prague, Czech Republic, May 24, 2020. Six of the infected employees are commuters from Poland. The testing related to the Darkov mine will continue until Monday.
                    Coal mine Darkov OKD, test, testing, epidemic coronavirus, employe, infection, protection, miner

                    Coal mine Darkov OKD, test, testing, epidemic coronavirus, employe, infection, protection, miner

                    The testing in the Darkov black-coal mine in Karvina (pictured May 23, 2020), north Moravia, has revealed 212 COVID cases, 154 of whom are miners or other employees of the mine, 54 are their family members and four work in other mines, Health Minister Adam Vojtech told journalists in Prague, Czech Republic, May 24, 2020. Six of the infected employees are commuters from Poland. The testing related to the Darkov mine will continue until Monday.
                      Coal mine Darkov OKD, test, testing, epidemic coronavirus, employe, infection, protection, miner

                      Coal mine Darkov OKD, test, testing, epidemic coronavirus, employe, infection, protection, miner

                      The testing in the Darkov black-coal mine in Karvina (pictured May 23, 2020), north Moravia, has revealed 212 COVID cases, 154 of whom are miners or other employees of the mine, 54 are their family members and four work in other mines, Health Minister Adam Vojtech told journalists in Prague, Czech Republic, May 24, 2020. Six of the infected employees are commuters from Poland. The testing related to the Darkov mine will continue until Monday.